Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...
Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...
The combination therapy is intended to treat NSCLC in individuals with certain mutations. Credit: Ei Ywet / Shutterstock. Johnson & Johnson (J&J) has reported positive topline outcomes from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback